Spots Global Cancer Trial Database for Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
Official Title: Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
Study ID: NCT01556828
Interventions
Study Description
Brief Summary: The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Stanford University, School of Medicine, Stanford, California, United States
Contact Details
Name: Paul Khavari, MD
Affiliation: Stanford University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
